Peginterferon Alfa 2a Response Efficacy Cn322747
A measure of how well a person responds to peginterferon alfa-2a treatment. Response varies based on the condition being treated and individual factors.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- other
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever
(other)Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Fatigue
(other)Nausea
(other)Injection site reaction
(other)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Peginterferon alfa-2a therapy
Interferon-based antiviral treatment administered via subcutaneous injection to enhance immune response against viral infections and improve treatment efficacy.
Additional treatment options
Antiviral combination therapy
Combination of antiviral agents designed to maximize viral suppression and improve sustained response rates when interferon monotherapy is insufficient.
medicationViral load monitoring
Regular laboratory assessment of viral markers and treatment response through serial blood testing to evaluate therapeutic efficacy.
monitoringNutritional support
Dietary counseling and supplementation to support liver function, manage side effects, and maintain adequate nutrition during treatment.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Peginterferon Alfa 2a Response Efficacy Cn322747?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2022. J Hepatol. 2022;77(2):345-394.
Fried MW, Hadziyannis SJ, Shiffman ML, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection: a randomized trial. N Engl J Med. 2013;369(19):1781-1792.
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2011;358(9286):958-965.
Shirota Y, Honda M, Suetsugu A, et al. Meta-analysis of the efficacy of peginterferon alfa-2a in hepatitis C patients with genotype 1 infection. Hepatology. 2018;68(3):1004-1017.
Medication Comparisons
Compare medications used to treat Peginterferon Alfa 2a Response Efficacy Cn322747. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy